Female sexual dysfunction: An appraisal of Canadian clinical practice guidelines using the AGREE II instrument.

Saved in:
Bibliographic Details
Title: Female sexual dysfunction: An appraisal of Canadian clinical practice guidelines using the AGREE II instrument.
Authors: Tomalty, Diane, Giovannetti, Olivia, Sa, Victoria, Adams, Michael A.
Source: Canadian Journal of Human Sexuality. Apr2023, Vol. 32 Issue 1, p115-125. 11p.
Subjects: Medical databases, Female reproductive organ diseases, Sexual dysfunction, Research methodology, Evidence-based medicine, Medical protocols, Full-text databases, Quality assurance, Descriptive statistics
Geographic Terms: Canada
Abstract: Female sexual dysfunction (FSD) is a prevalent concern among Canadian women. While clinical practice guidelines (CPGs) are commonly relied upon to guide evidence-based decision making, the availability and quality of published Canadian CPGs for FSD is unknown. More broadly, there is also a paucity of literature, which has evaluated documents guiding Canadian CPG development. A search was conducted to identify Canadian documents describing CPG development processes. Eligible documents underwent full-text review to extract content pertaining to scope and target audience. A separate search was conducted to identify Canadian CPGs specific to FSD. Eligible documents underwent quality appraisal using the validated Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. Four documents outlining CPG development processes were identified. While there were similarities in the steps for CPG development, discrepancies in scope, target user, and affiliated development group across the Canadian methodologies were noted. One Canadian CPG specific to FSD was identified. This CPG scored highly in the domains of Scope and Purpose (79%), and Clarity of Presentation (86%), although it did not reach the same quality threshold for the remaining domains. Our results suggest the need for consistent guidelines that are implementable by Canadian CPG developers across the diverse clinical landscape, including women's sexual health. This is the first study to evaluate the quality of CPGs for FSD using the AGREE II instrument. Our appraisal identifies areas of weakness that should be considered when updating this CPG in the future and in the development of new CPGs in this field. [ABSTRACT FROM AUTHOR]
Copyright of Canadian Journal of Human Sexuality is the property of University of Toronto Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 163406911
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Female sexual dysfunction: An appraisal of Canadian clinical practice guidelines using the AGREE II instrument.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tomalty%2C+Diane%22">Tomalty, Diane</searchLink><br /><searchLink fieldCode="AR" term="%22Giovannetti%2C+Olivia%22">Giovannetti, Olivia</searchLink><br /><searchLink fieldCode="AR" term="%22Sa%2C+Victoria%22">Sa, Victoria</searchLink><br /><searchLink fieldCode="AR" term="%22Adams%2C+Michael+A%2E%22">Adams, Michael A.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Canadian+Journal+of+Human+Sexuality%22">Canadian Journal of Human Sexuality</searchLink>. Apr2023, Vol. 32 Issue 1, p115-125. 11p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Medical+databases%22">Medical databases</searchLink><br /><searchLink fieldCode="DE" term="%22Female+reproductive+organ+diseases%22">Female reproductive organ diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Sexual+dysfunction%22">Sexual dysfunction</searchLink><br /><searchLink fieldCode="DE" term="%22Research+methodology%22">Research methodology</searchLink><br /><searchLink fieldCode="DE" term="%22Evidence-based+medicine%22">Evidence-based medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+protocols%22">Medical protocols</searchLink><br /><searchLink fieldCode="DE" term="%22Full-text+databases%22">Full-text databases</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+assurance%22">Quality assurance</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Canada%22">Canada</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Female sexual dysfunction (FSD) is a prevalent concern among Canadian women. While clinical practice guidelines (CPGs) are commonly relied upon to guide evidence-based decision making, the availability and quality of published Canadian CPGs for FSD is unknown. More broadly, there is also a paucity of literature, which has evaluated documents guiding Canadian CPG development. A search was conducted to identify Canadian documents describing CPG development processes. Eligible documents underwent full-text review to extract content pertaining to scope and target audience. A separate search was conducted to identify Canadian CPGs specific to FSD. Eligible documents underwent quality appraisal using the validated Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. Four documents outlining CPG development processes were identified. While there were similarities in the steps for CPG development, discrepancies in scope, target user, and affiliated development group across the Canadian methodologies were noted. One Canadian CPG specific to FSD was identified. This CPG scored highly in the domains of Scope and Purpose (79%), and Clarity of Presentation (86%), although it did not reach the same quality threshold for the remaining domains. Our results suggest the need for consistent guidelines that are implementable by Canadian CPG developers across the diverse clinical landscape, including women's sexual health. This is the first study to evaluate the quality of CPGs for FSD using the AGREE II instrument. Our appraisal identifies areas of weakness that should be considered when updating this CPG in the future and in the development of new CPGs in this field. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Canadian Journal of Human Sexuality is the property of University of Toronto Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=163406911
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3138/cjhs.2022-0033
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 115
    Subjects:
      – SubjectFull: Medical databases
        Type: general
      – SubjectFull: Female reproductive organ diseases
        Type: general
      – SubjectFull: Sexual dysfunction
        Type: general
      – SubjectFull: Research methodology
        Type: general
      – SubjectFull: Evidence-based medicine
        Type: general
      – SubjectFull: Medical protocols
        Type: general
      – SubjectFull: Full-text databases
        Type: general
      – SubjectFull: Quality assurance
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Canada
        Type: general
    Titles:
      – TitleFull: Female sexual dysfunction: An appraisal of Canadian clinical practice guidelines using the AGREE II instrument.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tomalty, Diane
      – PersonEntity:
          Name:
            NameFull: Giovannetti, Olivia
      – PersonEntity:
          Name:
            NameFull: Sa, Victoria
      – PersonEntity:
          Name:
            NameFull: Adams, Michael A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 11884517
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Canadian Journal of Human Sexuality
              Type: main
ResultId 1